Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $18.2B | $16.7B | $16.5B | $17.6B | $19.1B | $18.4B | $21.3B | $22.0B | $29.1B | $32.4B | $34.9B | $37.9B | $39.7B | $42.0B | $48.6B | $153.7B | $160.6B | $174.3B | $180.6B | $195.2B |
Discover the top 20 best undervalued stocks to buy for Dec 2024, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Dec 2024, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Dec 2024.
As of today, Cigna Corporation's last 12-month Revenue is $230.7B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Cigna Corporation's Revenue growth was 21.5%. The average annual Revenue growth rates for Cigna Corporation have been 12.2% over the past three years, 12.2% over the past five years.
Over the last year, Cigna Corporation's Revenue growth was 21.5%, which is higher than industry growth of 0.1%. It indicates that Cigna Corporation's Revenue growth is Good.